Navigation Links
Quantum dots reviewed -- Could these nanoparticles hold the cure to cancer?

The worlds of medical and biological research are abuzz with the promises offered by nanoparticles known as semiconductor quantum dots. These Quantum Dots (QDs) have unique optical and electronic properties that make them suitable for breakthrough treatments such as the detection and destruction of cancer cells.

Just released on the nanotechnology website AZoNano, is a comprehensive review of the latest literature and studies into Quantum Dots. The review by Sandeep Kumar Vashist, Rupinder Tewari, Ram Prakash Bajpai, Lalit Mohan Bharadwaj and Roberto Raiteri, researchers from a range of Italian and Indian universities and research organisations, has been released as part of AZoJono*, the open access AZo Journal of Nanotechnology Online.

With a focus on the use of QDs in cancer detection and treatment, the review includes a detailed examination of Quantum Dot advantages, their synthesis, properties and applications, toxic effects, use in imaging and analysis plus Quantum Dot drug delivery systems. The paper also outlines some early success in the detection and treatment of breast cancer.

The paper concludes with a quick look at what the future may hold for Quantum Dots in providing new insights into understanding the pathophysiology of cancer and real time imaging and screening of tumours.

The level of details provided in this valuable review paper could easily make up a chapter in an expensive text book. However, this paper is available to access free of charge in its entirety at http://www.azonano.com/Details.asp?ArticleID=1726
'"/>

Source:AZoNetwork


Page: 1

Related biology news :

1. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
2. Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections
3. Connect the Quantum Dots
4. First Quantum Grant to fund stem cell repair of damage from stroke
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. Spider Venom Could Yield Eco-Friendly Insecticides
7. New Breast Cancer Test Could Save Lives
8. Discovery Could Lead To Novel Approaches In HIV Treatment
9. New Drugs For Bad Bugs: UF Approach Could Bolster Antibiotic Arsenal
10. Protein Discovery Could Unlock The Secret To Better TB Treatment
11. Could microbes solve Russias chemical weapons conundrum?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant ... At PTE ... March, Materna will present its complete end-to-end passenger journey, ... real benefit for passengers. To accelerate the whole passenger handling ... solutions to take passengers through the complete integrated process with ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... 2017 MiMedx Group, Inc. (NASDAQ: MDXG), the ... tissue allografts and patent-protected processes to develop and market ... announced today  that it will present at the Needham ... NY.  Parker H. "Pete" Petit, Chairman and CEO, ... M. Cashman , EVP and Chief Commercialization Officer, and ...
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), ... for solid tumor cancers, today announced that yesterday ... announced last Friday, March 17, 2017. ... securities totaling 28,843,692 shares, comprised of 18,843,692 common ... of Class C Warrants pre-funded at the closing ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
Breaking Biology Technology: